Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

NEXTCURE, INC.

(NXTC)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur NEXTCURE, INC.
2021NEXTCURE : ASH 2021 – Siglec-15 is a Novel Immunomodulatory Protein and Therapeutic ..
2021NEXTCURE : ASH 2021 – A Novel LAIR-1 Antibody Target Acute Myeloid Leukemia (AML) St..
2021NextCure and Collaborators Provide Data on Targets in Development at American Society o..
2021NextCure, Inc. and Collaborators Provide Data on Targets in Development at American Soc..
2021NextCure to Present at The JMP Securities Hematology and Oncology Summit
2021NextCure to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
2021NEXTCURE : and Collaborators Provide Clinical and Research Updates on NC318 and NC410 Cand..
2021NEXTCURE, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
2021SITC 2021 ORAL PRESENTATION : Clinical benefit through Siglec-15 targeting with NC318 anti..
2021NextCure and Collaborators Provide Clinical and Research Updates on NC318 and NC410 Can..
2021NextCure and Collaborators Provide Clinical and Research Updates on NC318 and NC410 Can..
2021SITC 2021 Poster - NC410, a fusion protein of LAIR-2 fused to human IgG1 Fc is safe and..
2021NextCure Reports Third Quarter 2021 Financial Results and Provides Business Update - Fo..
2021NEXTCURE, INC. Management's Discussion and Analysis of Financial Condition and Results..
2021NextCure, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep..
2021NextCure Reports Third Quarter 2021 Financial Results and Provides Business Update
2021NextCure Announces Presentations on Targets in Development by Collaborators at American..
2021NextCure to Host Virtual Oncology Pipeline Update Event on November 15, 2021
2021NEXTCURE : Announces Three New Members of its Scientific Advisory Board
2021NextCure, Inc. Announces Advisory Board Changes
2021NEXTCURE : Announces Publication of Preclinical Data for NC410
2021NextCure, Inc. Announces Publication of Preclinical Data for NC410
2021NEXTCURE : Announces New Appointments to its Board of Directors (Form 8-K)
2021NEXTCURE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Fina..
2021NEXTCURE : Announces New Appointments to its Board of Directors
2021NextCure, Inc. Announces Board Appointments
2021NEXTCURE : to Give Three Presentations at Society for Immunotherapy of Cancer Annual Meeti..
2021NextCure, Inc. Announces New Data from Two Clinical Studies and One Research Study to B..
2021NEXTCURE, INC. : Change in Directors or Principal Officers (form 8-K)
2021NextCure, Inc. Announces Resignation of Stella Xu from the Board of Directors, Effectiv..
2021NextCure to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
2021NEXTCURE : to Present at the 19th Annual Morgan Stanley Global Healthcare Conference
2021NEXTCURE : H. C. Wainwright 23rd Annual Global Investment Conference Presentation
2021NEXTCURE : Management's Discussion and Analysis of Financial Condition and Results of Oper..
2021NEXTCURE : Reports Second Quarter 2021 Financial Results
2021Nextcure, Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Mont..
2021NEXTCURE : Launches Phase 1/2 Trial of NC762 Drug Candidate For Solid Tumors
2021NEXTCURE : Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors
2021NextCure Inc. Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors
2021NEXTCURE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell Small Cap Comp Value Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell 3000 Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell 3000E Growth Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell Small Cap Comp Growth Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell 2000 Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) added to Russell Microcap Value Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell 2500 Growth Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) added to Russell Microcap Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell 3000 Value Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell 3000 Growth Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell 2500 Value Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell 2000 Growth Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell 2000 Value Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell 2500 Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell 2000 Dynamic Index
2021NEXTCURE, INC.(NASDAQGS : NXTC) dropped from Russell Small Cap Completeness Index
2021NextCure and Collaborators Publish Preclinical Data on Novel Immunomedicine NC410
2021Nextcure and Collaborators Publish Preclinical Data on Novel Immunomedicine Nc410
2021NextCure to Present at the JMP Securities Life Sciences Conference
2021NextCure to Present Trials in Progress Poster for NC410 at the 2021 American Society of..
2021NEXTCURE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021NextCure Reports First Quarter 2021 Financial Results
2021NEXTCURE : Management's Discussion and Analysis of Financial Condition and Results of Oper..
2021NextCure, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31,..
2021NextCure to Present at the BofA Securities 2021 Virtual Health Care Conference
2021NextCure to Present at the 7th Annual Truist Securities Life Sciences Summit
2021NEXTCURE : Presents Preclinical Data for NC762 at American Association for Cancer Research..
2021NextCure Presents Preclinical Data for NC762 at American Association for Cancer Researc..
2021NextCure to Present at the 20th Annual Needham Virtual Healthcare Conference
2021NEXTCURE : Management's Discussion and Analysis of Financial Condition and Results of Oper..
2021NEXTCURE : Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financia..
2021NextCure, Inc. Reports Earnings Results for the Year Ended December 31, 2020
2021REMINDER : NextCure to Host Virtual R&D Update Event on March 4, 2021
2021NextCure to Host Virtual R&D Update Event on March 4, 2021
2021NEXTCURE, INC. : Change in Directors or Principal Officers (form 8-K)
1  2  3Suiv.
Prochain événement sur NEXTCURE, INC.